logo

Neurocrine Biosciences Inc (NBIX)



Trade NBIX now with
  Date
  Headline
6/16/2020 7:04:51 AM Neurocrine Biosciences, Takeda Announce Strategic Collaboration To Develop Early-to-mid-stage Psychiatry Pipeline
6/8/2020 11:02:20 AM Neurocrine Biosciences Reports Positive Data From Phase II Clinical Study Of Crinecerfont
5/11/2020 4:05:13 PM Neurocrine Biosciences Exercises Option To License Idorsia's Novel Treatment For Rare Pediatric Epilepsy
5/6/2020 4:07:20 PM Neurocrine Biosciences Q1 EPS $0.39 Vs. Loss $1.12 Year Ago
4/27/2020 7:33:24 AM Neurocrine Biosciences: FDA Approves ONGENTYS As Add-On Treatment For Parkinson's Disease Experiencing "Off" Episodes
4/3/2020 8:32:59 AM Neurocrine Biosciences Provides COVID-19 Business Update; Plans In Place To Launch Opicapone Later This Year
2/4/2020 4:03:14 PM Neurocrine Biosciences Q4 EPS $0.35 Vs. $0.19 Year Ago
2/3/2020 5:01:15 PM Neurocrine Biosciences Appoints Shalini Sharp To Board Of Directors